Therapeutic cloning in the mouse
- 30 September 2003
- journal article
- review article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (suppl_1) , 11924-11925
- https://doi.org/10.1073/pnas.1934141100
Abstract
Nuclear transfer technology can be applied to produce autologous differentiated cells for therapeutic purposes, a concept termed therapeutic cloning. Countless articles have been published on the ethics and politics of human therapeutic cloning, reflecting the high expectations from this new opportunity for rejuvenation of the aging or diseased body. Yet the research literature on therapeutic cloning, strictly speaking, is comprised of only four articles, all in the mouse. The efficiency of derivation of embryonic stem cell lines via nuclear transfer is remarkably consistent among these reports. However, the efficiency is so low that, in its present form, the concept is unlikely to become widespread in clinical practice.Keywords
This publication has 11 references indexed in Scilit:
- Nuclear Transplantation, Embryonic Stem Cells, and the Potential for Cell TherapyNew England Journal of Medicine, 2003
- Derivation of Oocytes from Mouse Embryonic Stem CellsScience, 2003
- Correction of a Genetic Defect by Nuclear Transplantation and Combined Cell and Gene TherapyCell, 2002
- Monoclonal mice generated by nuclear transfer from mature B and T donor cellsNature, 2002
- Differentiation of Embryonic Stem Cell Lines Generated from Adult Somatic Cells by Nuclear TransferScience, 2001
- Mouse embryonic stem (ES) cell lines established from neuronal cell-derived cloned blastocystsGenesis, 2000
- Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nucleiCurrent Biology, 2000
- Full-term development of mice from enucleated oocytes injected with cumulus cell nucleiNature, 1998
- Viable offspring derived from fetal and adult mammalian cellsNature, 1997
- Nuclear transplantation in sheep embryosNature, 1986